Market Insight Agent – Prognica Labs

Market & Commercial Insight

Market Validation, Asset Prioritization, and Commercial Strategy

An AI-driven analytics engine that bridges scientific discovery with commercial reality. Designed to evaluate the true market potential of drug assets, it integrates predictive modeling, real-world data, and economic intelligence to estimate unmet need, addressable market, payer sentiment, and reimbursement feasibility.

Pharma & Biotech
Prioritize programs with the highest likelihood of commercial success

Investors & VCs
Assess market-fit and exit potential before capital allocation

Strategy Firms
Model pricing, reimbursement, and payer readiness

Academic Institutions
Evaluate market feasibility for spinouts and licensing deals

Quantifies total addressable market (TAM), serviceable obtainable market (SOM), and forecasted growth potential based on epidemiological, demographic, and economic data. Employs predictive econometric models to simulate market uptake, pricing elasticity, and competitive displacement scenarios.

Uses clinical trial registries, prescription datasets, and patient outcome records to identify disease areas with high unmet need. Maps the clinical and regulatory landscape to pinpoint white-space opportunities.

Evaluates freedom-to-operate (FTO), patent density, and IP overlap across global jurisdictions. Cross-references competitive pipelines to identify open innovation niches and differentiation potential.

AI-generated go-to-market analogues compare each asset’s trajectory with historical case studies of similar therapeutics. Estimates potential deal valuations, licensing probabilities, and exit timelines for partnering or acquisition.

Full-Stack Evaluation
From scientific validity to market viability

Predictive Intelligence
AI models trained on real-world market outcomes

Early Validation
Integrates pricing, IP, & payer data before costly clinical investment

Exit-Oriented Insight
Quantifies commercial attractiveness and acquisition potential

Want to see a demo or
got a question, idea, or partnership in mind?